Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
Silvia Stacchiotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Ofer Merimsky(Tel Aviv Sourasky Medical Center), J. Gutkovich(NYU Langone Health), Nadia Hindi(Hospital Universitario Fundación Jiménez Díaz), Thomas Brodowicz(Vienna General Hospital), Javier Martín‐Broto(Hospital Universitario Fundación Jiménez Díaz), Hans Gelderblom(Leiden University Medical Center), R. Biagini(Tumori Foundation), Stefan Bielack(Olgahospital), Rebecca A. Gladdy(Princess Margaret Cancer Centre), Sebastian Bauer(Science for Life Laboratory), Paul H. Huang(Institute of Cancer Research), Virginia Ferraresi(Cancer Institute (WIA)), Akira Kawai(NTT (Japan)), Rick L. Haas(Leiden University Medical Center), Mikael Eriksson(Herlev Hospital), M. Deoras-Sutliff, Jean‐Yves Blay(Université Claude Bernard Lyon 1), Peter Hohenberger(University of Mannheim), Armelle Dufresne(Centre Léon Bérard), Christina Messiou(Institute of Cancer Research), Robin L. Jones(Institute of Cancer Research), Giovanni Grignani(Candiolo Cancer Institute), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Kjetil Boye(Oslo University Hospital), А. А. Феденко(P.A. Hertzen Moscow Oncology Research Institute), Anna Maria Frezza(University of Milan), Xavier García del Muro(Institut Català d'Oncologia), Sylvie Bonvalot(Dana-Farber Cancer Institute), Aisha Miah(Institute of Cancer Research), Costantino Errani(Istituto Ortopedico Rizzoli), Bernd Kasper(Heidelberg University), Carlo Morosi(Fondazione IRCCS Istituto Nazionale dei Tumori), I. Boukovinas, Andreas Leithner(Medical University of Graz), Judith V.M.G. Bovée(Leiden University Medical Center), Cristina R. Antonescu(Memorial Sloan Kettering Cancer Center), F. Gouin(Centre Léon Bérard), Christiane Jungels(Université Libre de Bruxelles), Franel Le Grange(University College London Hospitals NHS Foundation Trust), Axel Le Cesne(Institut Gustave Roussy), Heikki Joensuu(Orion Corporation (Finland)), Jyoti Bajpai(Homi Bhabha National Institute), Andrea Ferrari(University of Milan), Hugh Leonard, Augusto Caraceni(University of Milan), Elizabeth H. Baldini(Dana-Farber Cancer Institute), Dario Callegaro(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 189
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k